Activation of the JAK/STAT pathway in Behcet’s disease (original) (raw)
Direskeneli H . Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 2006; 45: 1461–1465. ArticleCAS Google Scholar
Hughes T, Coit P, Adler A, Yilmaz V, Aksu K, Düzgün N et al. Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease. Nat Genet 2013; 45: 319–324. ArticleCAS Google Scholar
Frassanito M, Dammacco R, Cafforio P, Dammacco F . Th1 polarization of the immune response in Behcet's disease. Arthritis Rheum 1999; 42: 1967–1974. ArticleCAS Google Scholar
Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C et al. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 2005; 139: 371–378. ArticleCAS Google Scholar
Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S et al. Type 17 T helper cells-origins, features and possible roles in rheumatic disease. Nat Rev Rheumatol 2009; 5: 325–331. ArticleCAS Google Scholar
Hreggvidsdottir HS, Noordenbos T, Baeten DL . Inflammatory pathways in spondyloarthritis. Mol Immunol 2014; 57: 28–37. ArticleCAS Google Scholar
Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010; 42: 698–702. ArticleCAS Google Scholar
Hamzaoui K . Th17 cells in Behcet's disease: a new immunoregulatory axis. Clin Exp Rheumatol 2011; 29: S71–S76. PubMed Google Scholar
Direskeneli H, Fujita H, Akdis CA . Regulation of TH17 and regulatory T cells in patients with Behcet disease. J Allergy Clin Immunol 2011; 128: 665–666. ArticleCAS Google Scholar
Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H et al. Upregulated IL-23 and IL-17 in Behcet patients with active uveitis. Invest Ophthalmol Vis Sci 2008; 49: 3058–3064. Article Google Scholar
Geri G, Terrier B, Rosenzwajg M, Wechsler B, Touzot M, Seilhean D et al. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behcet disease. J Allergy Clin Immunol 2011; 128: 655–664. ArticleCAS Google Scholar
Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A et al. Expression of Th-17 and RORgammat mRNA in Behcet's Disease. Med Sci Monit 2011; 17: CR227–CR234. ArticleCAS Google Scholar
Liu X, Yang P, Wang C, Li F, Kijlstra A . IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease. Rheumatology (Oxford) 2011; 50: 293–298. ArticleCAS Google Scholar
Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M et al. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet's disease. Arthritis Res Ther 2012; 14: R99. ArticleCAS Google Scholar
Murray PJ . The JAK-STAT signaling pathway: input and output integration. J Immunol 2007; 178: 2623–2629. ArticleCAS Google Scholar
O'Shea JJ, Holland SM, Staudt LM . JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 2013; 368: 161–170. ArticleCAS Google Scholar
Coskun M, Salem M, Pedersen J, Nielsen OH . Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 2013; 76: 1–8. ArticleCAS Google Scholar
Xavier JM, Krug T, Davatchi F, Shahram F, Fonseca BV, Jesus G et al. Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behcet's disease susceptibility. J Mol Med (Berl) 2013; 91: 1013–1023. ArticleCAS Google Scholar
O'Shea JJ, Plenge R . JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012; 36: 542–550. ArticleCAS Google Scholar
Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010; 32: 605–615. ArticleCAS Google Scholar
Kim J, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L et al. Imbalance of Th17 to Th1 cells in Behcet's disease. Clin Exp Rheumatol 2010; 28 (4 Suppl 60): S16–S19. PubMed Google Scholar
Shimizu J, Takai K, Fujiwara N, Arimitsu N, Ueda Y, Wakisaka S et al. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-gamma in patients with Behcet's disease. Clin Exp Immunol 2012; 168: 68–74. ArticleCAS Google Scholar
Na SY, Park MJ, Park S, Lee ES . Up-regulation of Th17 and related cytokines in Behcet's disease corresponding to disease activity. Clin Exp Rheumatol 2013; 31 (3 Suppl 77): 32–40. PubMed Google Scholar
Akman-Demir G, Tüzün E, Içöz S, Yeşilot N, Yentür SP, Kürtüncü M et al. Interleukin-6 in neuro-Behcet's disease: association with disease subsets and long-term outcome. Cytokine 2008; 44: 373–376. ArticleCAS Google Scholar
Qi J, Tüzün E, Içöz S, Yeşilot N, Yentür SP, Kürtüncü M et al. Increased Notch pathway activation in Behcet's disease. Rheumatology (Oxford) 2014; 44: 373–376. Google Scholar
Yang J, Stark GR . Roles of unphosphorylated STATs in signaling. Cell Res 2008; 18: 443–451. ArticleCAS Google Scholar
Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007; 21: 1396–1408. ArticleCAS Google Scholar
Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG et al. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem 2012; 287: 14192–14200. ArticleCAS Google Scholar
Hou S, Qi J, Zhang Q, Liao D, Li Q, Hu K et al. Genetic variants in the JAK1 gene confer higher risk of Behcet's disease with ocular involvement in Han Chinese. Hum Genet 2013; 132: 1049–1058. ArticleCAS Google Scholar
Hu K, Hou S, Jiang Z, Kijlstra A, Yang P . JAK2 and STAT3 polymorphisms in a Han Chinese population with Behcet's disease. Invest Ophthalmol Vis Sci 2012; 53: 538–541. ArticleCAS Google Scholar
Cenit MC, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ, Fernandez-Sueiro JL et al. Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease. Hum Immunol 2013; 74: 230–233. ArticleCAS Google Scholar
Oh HM, Ortego-Centeno N, Raya E, Callejas JL, García-Hernandez FJ, Castillo-Palma MJ et al. Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms. J Immunol 2011; 187: 3338–3346. ArticleCAS Google Scholar
Kovacic JC, Gupta R, Lee AC, Ma M, Fang F, Tolbert CN et al. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J Clin Invest 2010; 120: 303–314. ArticleCAS Google Scholar
Yeilding N, Szapary P, Brodmerkel C, Benson J, Plotnick M, Zhou H et al. Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives—an update. Ann N Y Acad Sci 2012; 1263: 1–12. Article Google Scholar
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335: 1078–1080.
R Development Core Team. R: a language and environment for statistical computing 2013 R Foundation for Statistical Computing: Vienna, Austria.
Tusher VG, Tibshirani R, Chu G . Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116–5121. ArticleCAS Google Scholar